AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8200
-0.0600 (-6.82%)
At close: May 13, 2026, 4:00 PM EDT
0.8017
-0.0183 (-2.23%)
After-hours: May 13, 2026, 8:00 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $21.57 million as of May 13, 2026. Its market cap has increased by 387.64% in one year.
Market Cap
21.57M
Enterprise Value
54.31M
1-Year Change
387.64%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $21.57M, a decrease of -66.11%. That is a compound annual growth rate of -19.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 23.15M | 77.77% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 25.97M |
| Outlook Therapeutics | 25.91M |
| ABVC BioPharma | 25.20M |
| Longeveron | 24.53M |
| Marker Therapeutics | 24.18M |
| Serina Therapeutics | 23.84M |
| Lantern Pharma | 23.43M |
| Celularity | 22.21M |